Guggenheim Capital LLC Novartis Ag Transaction History

Guggenheim Capital LLC

  • $12 Billion
  • Q4 2024

A detailed history of Guggenheim Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Guggenheim Capital LLC holds 12,568 shares of NVS stock, worth $1.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,568
Previous 14,274 11.95%
Holding current value
$1.41 Million
Previous $1.64 Million 25.53%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$96.78 - $117.18 $165,106 - $199,909
-1,706 Reduced 11.95%
12,568 $1.22 Million
Q3 2024

Nov 13, 2024
SELL
$106.13 - $120.89 $609,716 - $694,513
-5,745 Reduced 28.7%
14,274 $1.64 Million
Q2 2024

Aug 14, 2024
BUY
$92.57 - $107.37 $325,476 - $377,512
3,516 Added 21.31%
20,019 $2.13 Million
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $25,627 - $29,178
269 Added 1.66%
16,503 $1.6 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $180,849 - $199,018
1,960 Added 13.73%
16,234 $1.64 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $32,208 - $35,744
-340 Reduced 2.33%
14,274 $1.45 Million
Q2 2023

Aug 11, 2023
SELL
$92.52 - $104.91 $123,699 - $140,264
-1,337 Reduced 8.38%
14,614 $1.47 Million
Q1 2023

May 10, 2023
BUY
$80.03 - $92.81 $346,529 - $401,867
4,330 Added 37.26%
15,951 $1.47 Million
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $446,122 - $546,330
5,905 Added 103.31%
11,621 $1.05 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $21,562 - $25,218
289 Added 5.33%
5,716 $435,000
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $40,582 - $47,250
-504 Reduced 8.5%
5,427 $458,000
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $282,547 - $319,616
-3,527 Reduced 37.29%
5,931 $520,000
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $131,345 - $145,238
1,648 Added 21.1%
9,458 $828,000
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $96,418 - $112,170
-1,179 Reduced 13.12%
7,810 $639,000
Q2 2021

Aug 13, 2021
SELL
$85.24 - $94.15 $248,900 - $274,918
-2,920 Reduced 24.52%
8,989 $820,000
Q1 2021

May 13, 2021
SELL
$83.5 - $98.47 $382,179 - $450,697
-4,577 Reduced 27.76%
11,909 $1.02 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $505,659 - $611,623
-6,477 Reduced 28.21%
16,486 $1.56 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $439,038 - $486,395
-5,345 Reduced 18.88%
22,963 $2 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $96,306 - $108,409
-1,190 Reduced 4.03%
28,308 $2.47 Million
Q1 2020

Jun 02, 2020
SELL
$70.67 - $99.01 $251,373 - $352,178
-3,557 Reduced 10.76%
29,498 $2.43 Million
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $471,347 - $532,927
-5,588 Reduced 14.46%
33,055 $3.13 Million
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $364,742 - $401,924
4,264 Added 12.4%
38,643 $3.36 Million
Q2 2019

Aug 14, 2019
SELL
$75.4 - $92.8 $741,709 - $912,873
-9,837 Reduced 22.25%
34,379 $3.14 Million
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $881,545 - $1.01 Million
11,704 Added 36.0%
44,216 $4.25 Million
Q4 2018

Feb 14, 2019
SELL
$73.66 - $82.02 $968,555 - $1.08 Million
-13,149 Reduced 28.8%
32,512 $2.79 Million
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $377,139 - $436,240
5,634 Added 14.08%
45,661 $3.93 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $223,550 - $252,651
-3,444 Reduced 7.92%
40,027 $3.03 Million
Q1 2018

May 15, 2018
BUY
$70.39 - $84.15 $80,103 - $95,762
1,138 Added 2.69%
43,471 $3.52 Million
Q4 2017

Feb 14, 2018
SELL
$72.33 - $77.64 $551,950 - $592,470
-7,631 Reduced 15.27%
42,333 $3.56 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $3.7 Million - $3.86 Million
49,964
49,964 $4.29 Million

Others Institutions Holding NVS

# of Institutions
1,477
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email